ADDRESSING AND PROPOSING SOLUTIONS FOR UNMET CLINICAL NEEDS IN THE MANAGEMENT OF MYELOPROLIFERATIVE NEOPLASM

Researchers recently published an article, “Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper,” resulting from a group discussion among an ad hoc constituted Panel of experts aimed at highlighting unmet clinical needs in the management of thrombotic risk and thrombotic events associated with myeloproliferative neoplasms (MPNs).

“In this review, we attempt to define the unmet clinical needs in Ph-neg MPN-associated thrombosis, which relate principally to an improvement in risk classification, trial design, and structured care delivery. For this aim, a group of experts was convened to participate in a special consensus project.”

Click here to read the full article published in the Blood Cancer Journal.